Topics
- Proactive Risk Management strategies
- The impact of the new EMA and FDA regulations
- Strategies and best practices in Signal Detection
- Guidelines on Adverse Event Reporting requirements
- Post-market pharmacovigilance
- The role of social media in the future of pharmacovigilance
- Data mining tactics
Who should Attend
SVP’s, C-Level Executives, Directors, VP’s and Chief Safety Officers from Biotechnology Organizations involved in:
- Drug Safety
- Pharmacovigilance
- Pharmacoepidemiology
- Risk Management
- Customer Engagement
- Drug / Product Safety
- Signal Detection
- REMS
- Patient/ Medical Safety
- Clinical Safety
- Medical Directors
- Safety IV/ Post Marketing Studios
